CBGL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CBGL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cannabis Global's Earnings per Share (Diluted) for the three months ended in May. 2022 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.
Cannabis Global's EPS (Basic) for the three months ended in May. 2022 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.
Cannabis Global's EPS without NRI for the three months ended in May. 2022 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2022 was $-0.02.
The historical data trend for Cannabis Global's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Global Annual Data | |||||||||||||||||||||
Trend | Aug12 | Aug13 | Aug14 | Aug15 | Aug16 | Aug17 | Aug18 | Aug19 | Aug20 | Aug21 | |||||||||||
Earnings per Share (Diluted) | Get a 7-Day Free Trial | - | -0.02 | -0.03 | -0.29 | -0.13 |
Cannabis Global Quarterly Data | ||||||||||||||||||||
Aug17 | Nov17 | Feb18 | May18 | Aug18 | Nov18 | Feb19 | May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | |
Earnings per Share (Diluted) | Get a 7-Day Free Trial | -0.04 | -0.02 | - | - | - |
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's PE Ratio distribution charts can be found below:
* The bar in red indicates where Cannabis Global's PE Ratio falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Cannabis Global's Earnings Per Share (Diluted) for the fiscal year that ended in Aug. 2021 is calculated as
Diluted Earnings Per Share (A: Aug. 2021 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Diluted Average) |
= | (-7.835 | - | 0) | / | 58.289 | |
= | -0.13 |
Cannabis Global's Earnings Per Share (Diluted) for the quarter that ended in May. 2022 is calculated as
Diluted Earnings Per Share (Q: May. 2022 ) | = | (Net Income | - | Preferred Dividends | / | Shares Outstanding (Diluted Average) |
= | (-0.475 | - | 0) | / | 516.732 | |
= | -0.00 |
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
Cannabis Global (OTCPK:CBGL) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Cannabis Global's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Jim L. Riley | director | C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071 |
Ghs Investments, Llc | 10 percent owner | 0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123 |
Hymers Iii R. Leslie | director, 10 percent owner | 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071 |
Arman Tabatabaei | director, officer: CEO, CFO | 520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071 |
Lauderdale Holdings, Llc | director, 10 percent owner, officer: CEO/President/CFO | 1919 NW 19 STREET, FT LAUDERDALE FL 33311 |
Harmel S Rayat | 10 percent owner | 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1 |
David A Gamache | director, officer: SECRETARY/TREASURER/CFO | 3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866 |
Meetesh V Patel | director, officer: PRESIDENT/CEO | 8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045 |
Pattiann Hiranandani | director | 3905 NATIONAL DRIVE, BURTONSVILLE MD 20866 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 01-06-2022
By GuruFocusNews GuruFocusNews • 01-26-2022
By ACCESSWIRE ACCESSWIRE • 03-17-2022
By ACCESSWIRE ACCESSWIRE • 03-14-2022
By ACCESSWIRE ACCESSWIRE • 10-11-2021
By ACCESSWIRE ACCESSWIRE • 08-03-2022
By ACCESSWIRE ACCESSWIRE • 10-13-2021
By ACCESSWIRE ACCESSWIRE • 07-20-2021
By ACCESSWIRE ACCESSWIRE • 01-20-2022
By ACCESSWIRE ACCESSWIRE • 11-10-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.